Goldman Sachs Group Inc 4 D Molecular Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,057,849 shares of FDMT stock, worth $67.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,057,849
Previous 816,343
274.58%
Holding current value
$67.3 Million
Previous $16.5 Million
489.05%
% of portfolio
0.02%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding FDMT
# of Institutions
157Shares Held
50.3MCall Options Held
718KPut Options Held
370K-
Vr Adviser, LLC New York, NY4.4MShares$96.8 Million12.03% of portfolio
-
Black Rock Inc. New York, NY4.28MShares$94.3 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.92MShares$86.3 Million3.74% of portfolio
-
Janus Henderson Group PLC London, X03.2MShares$70.3 Million0.06% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.03MShares$66.8 Million3.19% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $712M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...